CN113181104A - A navel dropping liquid for diabetic - Google Patents

A navel dropping liquid for diabetic Download PDF

Info

Publication number
CN113181104A
CN113181104A CN202110370375.7A CN202110370375A CN113181104A CN 113181104 A CN113181104 A CN 113181104A CN 202110370375 A CN202110370375 A CN 202110370375A CN 113181104 A CN113181104 A CN 113181104A
Authority
CN
China
Prior art keywords
umbilical
dropping liquid
ethanol
kidney
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110370375.7A
Other languages
Chinese (zh)
Inventor
田艳萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yisheng Medical Biotechnology Liaoning Co ltd
Original Assignee
Yisheng Medical Biotechnology Liaoning Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yisheng Medical Biotechnology Liaoning Co ltd filed Critical Yisheng Medical Biotechnology Liaoning Co ltd
Priority to CN202110370375.7A priority Critical patent/CN113181104A/en
Publication of CN113181104A publication Critical patent/CN113181104A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an umbilical dropping liquid for diabetic patients, which mainly comprises dogwood fruit, Chinese yam, prepared rehmannia root, ginseng, tuckahoe, alisma orientale, cortex moutan and the like. The traditional Chinese medicine composition combines the medicines, not only strengthens spleen and tonifies qi to supplement congenital, but also nourishes yin and kidney to nourish acquired, and has the effects of tonifying qi and yin, strengthening spleen and tonifying kidney, replenishing essence and reducing internal heat. The traditional Chinese medicine composition is mainly used for treating liver-kidney yin deficiency type diabetes patients with clinically sallow complexion, low voice, weakness of limbs, poor appetite, loose stool, soreness and weakness of waist and knees, dizziness, tinnitus, deafness, night sweat, spermatorrhea, sexual dysfunction and other symptoms, and has a remarkable curative effect, and the total treatment effective rate reaches 91%. And the patch is convenient to use and high in absorption rate, can avoid symptoms such as allergy and the like possibly caused by the patch, and has the compliance of a patient to navel dropping liquid up to 95%.

Description

A navel dropping liquid for diabetic
Technical Field
The invention relates to the technical field of diabetes medication, in particular to an umbilical dropping liquid for diabetics.
Background
Diabetes is a metabolic disease characterized by hyperglycemia. Hyperglycemia is caused by defects in insulin secretion, impaired biological action of insulin, or both. The chronic presence of hyperglycemia leads to chronic damage, dysfunction of various tissues, particularly the eye, kidney, heart, blood vessels, and nerves.
However, the application allergy rate of the sugar-reducing plaster in the market at present is as high as 50%, and the application time is as long as 24 hours, so that local allergy and pruritus of patients are caused, and the plaster is difficult to tolerate. Therefore, the umbilicus dropping liquid for the diabetic is designed, does not need adhesive plaster, avoids allergy, improves the absorption rate and ensures the treatment effect.
Disclosure of Invention
Therefore, based on the above background, the present invention provides an umbilical dropping liquid for diabetic patients, which does not require an adhesive tape, can prevent allergy, and can improve the absorption rate of a drug and ensure a therapeutic effect by administering the drug via the umbilical dropping liquid.
The technical scheme of the invention is as follows:
an umbilical dropping liquid for diabetic patients, which comprises the following raw materials:
corni fructus, rhizoma Dioscoreae, radix rehmanniae Preparata, Ginseng radix, Poria, Alismatis rhizoma, and cortex moutan.
Further, the feed comprises the following raw materials in parts by weight:
1 part of cornus pulp, 1 part of Chinese yam, 1 part of prepared rehmannia root, 1 part of ginseng, 1 part of tuckahoe, 1 part of rhizoma alismatis and 1 part of cortex moutan.
Further, the extraction steps of the umbilical dropping liquid of the invention are as follows:
s1: crushing the herbs in parts by weight, and sieving the crushed herbs with a sieve of 10-50 meshes;
s2: putting the herbal powder of S1 into 95% ethanol, and soaking in 95% ethanol for more than 24 h;
s3: percolating the powder with 95% ethanol solution 2-10 times the weight of the powder at a rate of 3-4 ml/min;
s4: percolating the herbal powder again with deionized water at 50-90 deg.C;
s5: collecting all the obtained extracts;
s6: evaporating the extract to obtain an extractive solution with a concentration of 1.6-2.2 relative density.
Further, in step S1, the herb is ground and then sieved through a 20-mesh sieve.
In the technical proposal, the device comprises a shell,
in the step S1, the medicinal herbs which are proportioned according to the parts by weight are crushed and then sieved by a 20-mesh sieve, so that the contact area of the medicinal powder of each raw material and ethanol can be increased, the medicinal herbs and the ethanol are uniformly mixed, the medicinal herbs can be easily soaked by the ethanol, and the leaching concentration of the medicinal herbs is increased, so that the extraction concentration of the medicinal herbs is increased;
step S2, the pulverized medicinal powder is put into 95% ethanol and soaked in the 95% ethanol for 24h, and similar compatibility of organic matters is realized, so that the medicine is conveniently leached into the ethanol, and the extraction concentration is increased;
step S3, percolating the medicinal herb powder with 95% ethanol solution 2-10 times of the medicinal herb powder at a speed of 3-4ml/min, wherein during downward flow of the ethanol penetrating through the medicinal material layer, the medicinal material components are leached out, and the dissolved ethanol is prevented from volatilizing by a dynamic leaching method, so that the utilization rate of the ethanol is improved, the effective components are completely leached out, and the leachate can be directly collected;
percolating the herbal powder again with deionized water at 50-90 deg.C in step S4; so as to leach medicinal components which are insoluble in ethanol, and further ensure that the medicinal components are leached and utilized more completely, thereby ensuring that the concentration of the leaching solution is higher;
collecting all the extracts obtained in the step S5 to be treated in a centralized way;
in step S6, by evaporating the extract, an extract with a concentration of 1.6-2.2 relative density is obtained after evaporation, so as to remove the excess liquid to obtain a certain concentration of medicinal components.
Preferably, the amount of deionized water used in step S4 is 2-10 times of the herbal powder, and the percolation rate is controlled to 3-4 ml/min.
Preferably, the evaporation temperature of step S6 is controlled at 80-100 ℃.
By evaporation in step S6, recovery may be performed by distilling off ethanol, and excess water may be distilled off to make the droplets reach an optimum concentration.
Further, the extraction method also comprises the following steps:
s7: dissolving 0.02-2 parts of menthol with 0.2-5 parts of propylene glycol, and adding the dissolved menthol into the extracting solution obtained in the step S6;
s8: adding 0.1-1 part of phenoxyethanol and 0.2-3 parts of polyoxyethylene (20) sorbitan monolaurate to solubilize the extract of S7 to obtain dripping liquid.
In step S7, menthol is added to selectively stimulate the human skin or mucous membrane cold receptors to produce cold reflex and cold sensation, which causes the skin mucous membrane to contract blood vessels (actually, the skin remains normal); in addition, the blood vessels in deep tissues can be contracted to produce a therapeutic effect. The external use can diminish inflammation, relieve pain, relieve itching, promote blood circulation, relieve edema and the like, and has the functions of invigorating stomach and dispelling wind;
the phenoxyethanol and the polyoxyethylene (20) sorbitan monolaurate added in the step S8 are increased, so that the dropping liquid can be directly dropped on the navel without adhesive plaster, and the allergy of the human body caused by the application is avoided; the medicament can be quickly absorbed within 5 minutes, and has higher absorptivity and better effect.
In the above-mentioned umbilical region drip liquid,
cornus officinalis: slightly warm in nature, sour and astringent in flavor, entering liver and kidney meridians. Has effects of invigorating liver and kidney, arresting seminal emission, and relieving depletion, and can be used for treating giddiness tinnitus, soreness of waist and knees, sexual impotence nocturnal emission, enuresis pollakisuria, metrorrhagia leukorrhagia, profuse sweat depletion, internal heat diabetes, etc.
Chinese yam: neutral in nature and sweet in flavor, enter spleen, lung and kidney meridians. Has effects of invigorating spleen and stomach, promoting fluid production and benefiting lung, invigorating kidney and arresting seminal emission, and can be used for treating spleen deficiency and anorexia, chronic diarrhea, lung deficiency and cough, kidney deficiency and nocturnal emission, leukorrhagia, pollakisuria, deficiency heat and diabetes etc.
Prepared rehmannia root: it is slightly warm in nature and sweet in flavor, entering liver and kidney meridians. Has effects in nourishing yin, tonifying blood, replenishing essence, and replenishing marrow, and can be used for treating liver and kidney yin deficiency, soreness of waist and knees, hectic fever, night sweat, spermatorrhea, internal heat, diabetes, and blood deficiency.
Ginseng: neutral in nature, sweet and slightly bitter in flavor, and entering spleen, lung and heart meridians. Has effects of invigorating primordial qi, restoring pulse, relieving depletion, invigorating spleen, benefiting lung, promoting fluid production, and tranquilizing mind, and can be used for treating diseases such as asthenia, desire for depletion, cold limbs, slight pulse, spleen deficiency, anorexia, lung deficiency, cough, asthma, thirst due to body fluid deficiency, internal heat, diabetes, asthenia, palpitation, and insomnia.
Tuckahoe, poria cocos: neutral in nature, sweet and bland in flavor, and entering heart, lung, spleen and kidney meridians. Has effects in promoting diuresis, eliminating dampness, invigorating spleen, and calming heart, and can be used for treating edema, oliguria, phlegm and fluid retention, dizziness, palpitation, spleen deficiency, anorexia, loose stool, diarrhea, uneasiness, palpitation, and insomnia.
Rhizoma alismatis: cold in nature and sweet in flavor, it enters kidney and bladder meridians. Has effects of promoting urination, clearing away damp-heat, etc., and can be used for treating dysuria, edema, abdominal distention, diarrhea, oliguria, phlegm retention, giddiness, heat stranguria, and pain.
Cortex moutan: is slightly cold in nature, bitter and pungent in taste, has the effects of clearing heat and cooling blood, promoting blood circulation and removing blood stasis, and can be used for treating warm-toxicity macula, hematemesis and epistaxis, night fever and early coolness, no sweat and bone steaming, amenorrhea and dysmenorrhea, carbuncle swelling and sore toxin, traumatic injury and pain, etc.
In the prescription, the dogwood fruit has the effects of nourishing the kidney and the liver, the Chinese yam has the effects of nourishing the kidney and the spleen, and the prepared rhizome of rehmannia has the effects of nourishing the kidney and the essence and marrow, and the combination of the dogwood fruit, the Chinese yam, the rehmannia glutinosa and the prepared rhizome has the effects of collecting the liver, the spleen and the kidney and tonifying the essence; ginseng, radix Ginseng, being sweet and warm, has effects of invigorating spleen and stomach, and invigorating primordial qi; rhizoma Alismatis and radix rehmanniae Preparata for purging kidney and descending turbid; the moutan bark, the pulp of dogwood fruit, and the tuckahoe, the yam, are used to drain the liver fire and enhance the spleen-invigorating effect.
The medicines are combined to strengthen the spleen and tonify qi to nourish the congenital, and nourish yin and tonify the kidney to nourish the acquired, so that the effects of tonifying qi and yin, strengthening the spleen and tonifying the kidney, replenishing essence and reducing fire are achieved.
By adopting the technical scheme, the beneficial effects are as follows:
the traditional Chinese medicines for tonifying spleen, supplementing qi and nourishing yin are combined, and the traditional Chinese medicine composition has obvious curative effect on the liver-kidney yin deficiency type diabetes mellitus patients with symptoms of sallow complexion, low voice, weakness of limbs, poor appetite, loose stool, soreness and weakness of waist and knees, dizziness, tinnitus, deafness, night sweat, spermatorrhea, sexual hypofunction, bone-steaming tidal fever, feverish sensation in the palms and soles, deficiency fire, toothache, thirst, dry mouth and throat, pale tongue with thin and white coating, or red tongue with little coating, thin and slow pulse or thready pulse and the like clinically, and the total curative effect reaches 91%. And the patch is convenient to use and high in absorption rate, can avoid symptoms such as allergy and the like possibly caused by the patch, and has the compliance of a patient to navel dropping liquid up to 95%.
Drawings
The above and/or additional aspects and advantages of the present invention will become apparent and readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings of which:
FIG. 1 shows a flow diagram of an extraction process for an umbilical drop for a diabetic patient according to one embodiment of the present invention;
FIG. 2 illustrates a flow chart of an extraction and deployment process for an umbilical drop for a diabetic patient according to another embodiment of the present invention;
FIG. 3 shows a flow diagram of an extraction and deployment process for an umbilical drop for a diabetic patient according to yet another embodiment of the present invention;
FIG. 4 shows a flow diagram of an extraction and deployment process for an umbilical drop for a diabetic patient according to yet another embodiment of the present invention;
FIG. 5 shows a flow diagram of an extraction and deployment process for an umbilical drop for a diabetic patient according to yet another embodiment of the present invention.
Detailed Description
In order that the above objects, features and advantages of the present invention can be more clearly understood, a more particular description of the invention will be rendered by reference to the appended drawings. It should be noted that the embodiments and features of the embodiments of the present application may be combined with each other without conflict.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention, however, the present invention may be practiced in other ways than those specifically described herein, and therefore the scope of the present invention is not limited by the specific embodiments disclosed below.
Example 1: umbilical dripping for diabetic patients according to some embodiments of the present invention is described below with reference to fig. 1-5.
In an embodiment of the present invention, as shown in fig. 1 to 5, the present invention provides an umbilical region dropping liquid for diabetic patients, which is composed of the following raw materials in parts by weight: 1 part of cornus pulp, 1 part of Chinese yam, 1 part of prepared rehmannia root, 1 part of ginseng, 1 part of tuckahoe, 1 part of rhizoma alismatis and 1 part of cortex moutan.
In one embodiment of the present invention, preferably, as shown in fig. 1, the extraction procedure of an umbilical drop for diabetic patients in the present invention is as follows:
s1: crushing the herbs in parts by weight and then sieving the crushed herbs with a 20-mesh sieve;
s2: putting the pulverized medicinal powder into 95% ethanol, and soaking in 95% ethanol for 24 hr;
s3: percolating the medicinal herb powder with 95% ethanol solution 6 times the medicinal herb powder at a speed of 3-4 ml/min;
s4: percolating the herbal powder again with deionized water at 80 deg.C;
s5: collecting all the obtained extracts; s6, evaporating the extract to obtain extract with concentration relative density of 2.0.
In the embodiment, in the step S1, the herbs proportioned according to the parts by weight are crushed and then sieved by a 20-mesh sieve, so that the contact area between the herbs and the ethanol is increased, the herbs and the ethanol are uniformly mixed, the ethanol is easier to permeate the herbs, the leaching concentration of the herbs is increased, and the extraction concentration of the herbs is increased;
s2, putting the crushed medicinal powder into 95% ethanol, soaking in 95% ethanol for 24h, and leaching the medicinal powder into the ethanol through similar compatibility of organic matters, so as to increase the extraction concentration;
s3, percolating the medicinal herb powder with 95% ethanol solution 6 times the mass of the medicinal herb powder at a speed of 3-4ml/min, wherein during the downward flow of the ethanol penetrating through the medicinal herb layer, the medicinal herb component is leached out, and the dissolved ethanol is prevented from volatilizing by a dynamic leaching method, so that the utilization rate of the ethanol is improved, the effective components are completely leached out, and the leachate can be directly collected;
s4, percolating the herbal powder again with deionized water at 80 ℃; so as to leach medicinal components which are insoluble in ethanol, and further ensure that the medicinal components are leached and utilized more completely, thereby ensuring that the concentration of the leaching solution is higher;
collecting all the extracts obtained in S5 for centralized treatment; s6, evaporating the extract to obtain extractive solution with concentration relative density of 2.0, and removing excessive liquid to obtain medicinal material components with certain concentration.
In one embodiment of the present invention, preferably, as shown in figure 2,
a dispensing process for an umbilical drop for a diabetic patient further comprising:
s7, dissolving 0.1 part of menthol by 1 part of propylene glycol; s8, adding 0.3 part of phenoxyethanol and 0.8 part of polyoxyethylene (20) sorbitan monolaurate to solubilize the extract, and obtaining the dropping liquid.
In the step S7, dissolving 0.1 parts of menthol with 1 part of propylene glycol can selectively stimulate the human skin or mucous membrane cold receptors to generate cold reflex and cold feeling, and cause the skin mucous membrane to contract blood vessels (actually, the skin remains normal); in addition, the blood vessels in deep tissues can be contracted to produce a therapeutic effect. The external use can diminish inflammation, relieve pain, relieve itching, promote blood circulation, relieve edema and the like, and has the functions of invigorating stomach and dispelling wind;
0.3 part of phenoxyethanol and 0.8 part of polyoxyethylene (20) sorbitan monolaurate are added in the step S8 to solubilize the extracting solution, and the obtained dropping liquid can be directly dropped on the navel without being pasted by adhesive tape so as to avoid the allergy of the human body caused by pasting; the medicament can be quickly absorbed within 5 minutes, and has higher absorptivity and better effect.
In one embodiment of the present invention, it is preferable that the extraction process of the umbilical dropping liquid for diabetic patients as shown in fig. 3 is performed by pulverizing the herb and sieving the pulverized herb with a 20-mesh sieve in step S1, which is S1.
In one embodiment of the present invention, it is preferable that the extraction process of the umbilical dropping liquid for diabetic patients as shown in fig. 4 is performed by using deionized water 6 times (i.e., S4.1) the amount of the herb powder in step S4, and the percolation rate is controlled to 3-4ml/min (i.e., S4.2).
In this example, the herbal powder was again percolated with deionized water 6 times the mass of the herbal powder in S4.1; and S4.2, controlling the percolation speed of the deionized water to be 3-4ml/min to ensure that the medicinal material which is insoluble in ethanol is leached by using enough water, so that the concentration of the medicinal material component which is soluble in ethanol is consistent with that of the medicinal material component which is insoluble in ethanol.
In one embodiment of the present invention, it is preferable that the extraction process of the umbilical dropping liquid for diabetic patients as shown in fig. 5, in step S6, the evaporation temperature is controlled at 100 ℃ to recover ethanol (i.e., S6.1).
In this example, the evaporation temperature in S6.1 is controlled at 100 deg.C, and the boiling point of ethanol is higher, so that the ethanol is completely distilled out, and the excessive water is distilled to reach the optimal concentration of the dripping liquid.
Compared with the oral dosage form of the formula, the umbilical dropping liquid prepared in the example 1 has the advantages that the compliance of a patient to the umbilical dropping liquid (the patient compliance is 95%) is obviously higher than the compliance of the decoction when the decoction is taken orally (the patient compliance is 63%), and the umbilical dropping liquid is absorbed through the umbilical mucosa and has no mouth bitter compared with the oral dosage form. It is more suitable for patients with liver-kidney yin deficiency type diabetes, and has an effective rate up to 93%.
Example 2: typical case
Wangzhi, male, age 63, waist circumference: 78cm, height: 175cm, body weight 75kg, BMI: 24.5kg/m 2.
The main complaints are: thirst with more than 20 years of drinking, tinnitus and deafness for 10 years, aggravation with dizziness and hypodynamia for 1 week.
The current medical history: patients have no obvious inducement before 20 years, have dry mouth, polydipsia and hypodynamia, are diagnosed with type 2 diabetes in local hospitals, and do not take any hypoglycemic drugs. The patients have deafness and tinnitus before 10 years, the patients are diagnosed in local hospitals, the blood sugar is found to be obviously increased (the specific numerical value is unknown), the insulin and the oral medicine are used for controlling the blood sugar, the blood sugar reducing medicines are discontinuously used for years, the blood sugar fluctuation is large, the tinnitus and the deafness are suddenly aggravated before 1 week, and the dizziness, the blurred vision, the low voice, the weakness of limbs, the poor appetite, the loose stool and the sallow complexion are accompanied at the same time, and the patients are diagnosed in the local hospitals after the treatment, and the fasting venous blood sugar is measured: 17.9mmol/L, 2 hours postprandial venous blood glucose: 22.6mmol/L, glycated hemoglobin: 15.3%, urinary protein: ++. The patient has no fever, nausea, vomiting, abdominal pain, diarrhea and rotten apple flavor after the onset of the disease. History of the past: deny the history of hypertension and coronary heart disease. The patients have definite diabetes diagnosis, continue to eat low-salt and low-fat diabetes diet, and simultaneously eat high-quality protein every day. The insulin glargine 20iu is subcutaneously injected before sleeping in combination with the insulin lispro 6iu is subcutaneously injected before three meals, the linagliptin is 5mg, the sugar is reduced by oral administration for 1 time per day, and the umbilical dropping liquid is added for 6 drops per time and twice per day. Retesting after 1 month, fasting venous blood sugar 8.1mmol/L, 2 hours after meal venous blood sugar: 10.2mmol/L, urine protein: +. The symptoms of self-complaint of soreness and weakness of waist and knees, light headedness, tinnitus and deafness are obviously relieved, and dizziness and hypodynamia are obviously improved. After 3 months, insulin is gradually reduced to be premixed with 30-day-early 16iu and 14iu of insulin aspart, navel dropping liquid is continuously combined with oral medicine for treatment, the blood sugar is well controlled, and the glycosylated hemoglobin: 8.7%, fasting blood sugar fluctuation is between 7.0-10.0mmol/L, blood sugar fluctuation at 2 hours after meal is between 8.2-12.3mmol/L, and no hypoglycemic event occurs
To summarize: the patients have sallow complexion, low voice, weakness of limbs, poor appetite, loose stool, soreness of waist and knees, dizziness, tinnitus and deafness, and are due to liver-kidney yin deficiency. Meanwhile, the disease course of the patient is long, and the navel dropping liquid of the dogwood fruit, the Chinese yam, the prepared rehmannia root, the ginseng, the tuckahoe, the rhizoma alismatis and the cortex moutan is used for tonifying spleen and qi to supplement the innate essence and nourishing yin and the kidney to nourish the acquired essence, so that the effects of tonifying qi and yin, strengthening spleen and tonifying kidney, replenishing essence and reducing pathogenic fire are achieved. Meanwhile, the traditional Chinese medicine composition is combined with western medicine for treatment, so that the blood sugar of a patient is effectively controlled, the symptoms are improved, the curative effect is exact, and the safety is good.
In the description of the present invention, the terms "plurality" or "a plurality" refer to two or more, and unless otherwise specifically limited, the terms "upper", "lower", and the like indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings, and are merely for convenience in describing the present invention and simplifying the description, but do not indicate or imply that the referred device or element must have a specific orientation, be constructed in a specific orientation, and be operated, and thus should not be construed as limiting the present invention; the terms "connected," "mounted," "secured," and the like are to be construed broadly and include, for example, fixed connections, removable connections, or integral connections; may be directly connected or indirectly connected through an intermediate. The specific meanings of the above terms in the present invention can be understood by those skilled in the art according to specific situations.
In the description of the present invention, the description of the terms "one embodiment," "some embodiments," "specific embodiments," etc., means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the present invention. In the present invention, the schematic representations of the terms used above do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (7)

1. An umbilical dropping liquid for diabetic patients is characterized by comprising the following raw materials:
corni fructus, rhizoma Dioscoreae, radix rehmanniae Preparata, Ginseng radix, Poria, Alismatis rhizoma, and cortex moutan.
2. The umbilical dropping liquid for the diabetic patient according to claim 1, which comprises the following raw materials in parts by weight:
1 part of cornus pulp, 1 part of Chinese yam, 1 part of prepared rehmannia root, 1 part of ginseng, 1 part of tuckahoe, 1 part of rhizoma alismatis and 1 part of cortex moutan.
3. An umbilical drop for a diabetic patient according to claim 1 or 2 wherein the umbilical drop is extracted by the steps of:
s1: crushing the medicinal herbs in parts by weight to 10-50 meshes;
s2: putting the herbal powder of S1 into 95% ethanol, and soaking in 95% ethanol for more than 24 h;
s3: percolating the powder with 95% ethanol solution 2-10 times the weight of the powder at a rate of 3-4 ml/min;
s4: percolating the herbal powder again with deionized water at 50-90 deg.C;
s5: collecting all the obtained extracts;
s6: evaporating the extract to obtain an extractive solution with a concentration of 1.6-2.2 relative density.
4. An umbilical dropping liquid for a diabetic patient according to claim 3,
the extraction also comprises the following steps:
s7: dissolving 0.02-2 parts of menthol with 0.2-5 parts of propylene glycol, and adding the dissolved menthol into the extracting solution obtained in the step S6;
s8: adding 0.1-1 part of phenoxyethanol and 0.2-3 parts of polyoxyethylene (20) sorbitan monolaurate to solubilize the extract of S7 to obtain dripping liquid.
5. The umbilicus dropping liquid for diabetic patients as claimed in claim 3, wherein step S1 is to pass through a 20 mesh sieve after pulverizing the herb.
6. An umbilical dropping liquid for a diabetic patient according to claim 3,
the amount of deionized water adopted in step S4 is 2-10 times of the herb powder, and the percolation speed is controlled at 3-4 ml/min.
7. An umbilical drop for a diabetic patient according to claim 3 wherein the evaporation temperature of step S6 is controlled to be 80-100 ℃.
CN202110370375.7A 2021-04-07 2021-04-07 A navel dropping liquid for diabetic Pending CN113181104A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110370375.7A CN113181104A (en) 2021-04-07 2021-04-07 A navel dropping liquid for diabetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110370375.7A CN113181104A (en) 2021-04-07 2021-04-07 A navel dropping liquid for diabetic

Publications (1)

Publication Number Publication Date
CN113181104A true CN113181104A (en) 2021-07-30

Family

ID=76974788

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110370375.7A Pending CN113181104A (en) 2021-04-07 2021-04-07 A navel dropping liquid for diabetic

Country Status (1)

Country Link
CN (1) CN113181104A (en)

Similar Documents

Publication Publication Date Title
CN101947284B (en) Traditional Chinese medicinal composition for treating diabetes and preparation method thereof
CN112007111A (en) A navel dropping liquid for diabetic
CN103495040B (en) Traditional Chinese medicine composition for treating reflux esophagitis and preparation method of granule formulation thereof
CN103749822B (en) A kind of fruit of glossy privet hypertension and hyperlipemia health protection tea and preparation method thereof
CN102166278B (en) Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof
CN102526498A (en) Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof
CN104083640B (en) Traditional Chinese medicinal composition for treating diabetes mellitus and preparation method thereof
CN113318192A (en) Umbilical dropping liquid for diabetic patients and preparation method thereof
CN104353029A (en) Lung-moistening tangerine peel paste and preparation method thereof
CN107625828A (en) A kind of health protection tea for auxiliary treatment chronic pharyngitis, preparation method and application
CN103735843A (en) Medicine composition for treating diabetes
CN105687788A (en) Pharmaceutical composition capable of softening blood vessels and application thereof
CN113181104A (en) A navel dropping liquid for diabetic
CN108186821B (en) Traditional Chinese medicine composition for treating nervous headache and preparation method and application thereof
CN1192789C (en) 'Shenhuaxiaokecha' tea and preparing method thereof
CN105250758A (en) Traditional Chinese medicine composition for treating diabetes
CN105169078A (en) Traditional Chinese medicinal composition for treating diabetes
CN105663439A (en) Pharmaceutical composition for preventing and treating diabetes and preparation method thereof
CN103989940A (en) Traditional Chinese medicine composition for treating diabetes mellitus
CN113018384A (en) A navel dropping liquid for diabetic
CN104524359B (en) A kind of Chinese medicine composition, its preparation method and application
CN110201056A (en) A kind of Chinese medicine composition and its preparation, preparation method and application
CN113144091A (en) A navel dropping liquid for diabetic
CN1308024C (en) Medicine for treating diabetes and its preparing method
CN114432410B (en) Blood circulation promoting and stasis removing paste formula and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210730

WD01 Invention patent application deemed withdrawn after publication